Heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) are age-
related conditions that are increasing in prevalence, commonly coexist, and share clinical …

Abstract Objectives: The PARAGON-HF (Prospective Comparison of ARNI with ARB Global
Outcomes in HF With Preserved Ejection Fraction) trial is designed to determine the efficacy …

Background Heart failure (HF) is a major health burden worldwide. However, there is no
nationwide epidemiological data on HF in China after 2000. The aims of this study are (i) to …

A organização de uma diretriz clínica é tarefa complexa, que necessariamente deve
envolver planejamento prévio, coordenação apropriada, revisão aprofundada da literatura …

Aims The objectives of the present study were to describe epidemiology and outcomes in
ambulatory heart failure (HF) patients stratified by left ventricular ejection fraction (LVEF) and …

5.2. 1. Ocena funkcji skurczowej lewej komory...................................... 1052 5.2. 2. Ocena
funkcji rozkurczowej lewej komory...................................... 1052 5.2. 3. Ocena funkcji prawej …

Aims Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous clinical
syndrome with multiple underlying causes. Wild-type transthyretin (TTR) amyloidosis …

Background: Heart failure (HF) is currently classified according to left ventricular ejection
fraction (LVEF); however, the prognostic value of LVEF is controversial. Myocardial strain is …

Background—Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone
Antagonist (TOPCAT) patients with heart failure and preserved left ventricular ejection …

Aims While mineralocorticoid receptor antagonists (MRAs) have been shown to benefit
patients with reduced left ventricular ejection fraction (LVEF), spironolactone did not reduce …